Hematologic Malignancies Testing Market Growth Factors, Company Profile Analysis, Research Methodology and Forecast to 2030
The global Hematologic Malignancies Testing Market had a size of USD 2.55 billion in 2021 and is expected to grow at a CAGR of 14.7% during the forecast period. Hematologic malignancies are cancers that develop in blood, bone marrow, and lymph nodes.
The rising prevalence of blood cancer, leukemia, and multiple myeloma worldwide, increasing healthcare spending, awareness among patients and...
0 Reacties
0 aandelen
10436 Views
English
العربية
Français
Español
Português
Deutsch
Türkçe
Italiano
Русский
Română
Português
Ελληνικά
Tiếng Việt